The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome in Oocyte Donors.
Phase of Trial: Phase II
Latest Information Update: 26 Mar 2013
At a glance
- Drugs Cetrorelix (Primary)
- Indications Ovarian hyperstimulation syndrome
- Focus Therapeutic Use
- 13 Oct 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
- 13 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Apr 2009 New trial record